Mots-clés
Thésaurus mots-clés > Substances chimiques > Substances psychotropes > Pertubateurs du SNC > DROGUES DE SYNTHESE
DROGUES DE SYNTHESESynonyme(s)DESIGNER DRUGS NPS |
Documents disponibles dans cette catégorie (1358)
Brochure
ENGLISH : Within the framework of the joint Action of 16 June 1997, the Early-warning System (EWS) aims to create a mechanism for the rapid exchange of information on the production, traffic, use and risks of new synthetic drugs. Taking into a[...]Périodique
HARDINGHAUS N. H. | 1996Cet article, déjà publié en 1995 dans la revue Nueva Sociedad au Vénézuela, brosse les grandes tendances et implications du marché de la drogue au niveau mondial : pays producteurs, pays consommateurs ; offres traditionnelles (cannabis, opium et[...]Rapport
L'objectif de cette étude est de révéler l'ampleur et la nature de la menace représentée par les stimulants de type amphétaminiques dans le monde d'aujourd'hui, en portant un regard sur ce que les sociétés peuvent mettre en place pour lutter con[...]Article : Périodique
Ecstasy et autres produits de synthèse en France. Etat des lieux issu du dispositif SINTES 1999-2002
FRANÇAIS : Crée en 1999, dans le cadre des orientations du Plan triennal de lutte contre la drogue et de prévention des dépendances, SINTES (Système national de surveillance des toxiques et substances) délivre des informations sur les drogues d[...]Rapport
Le présent document a comme objectif de présenter la situation qui prévaut au Québec, une description détaillée de l'ecstasy, de ses effets, de ses dangers, de son contexte d'utilisation, des personnes touchées et des produits associés.Chapitre
G. GIRARD ; G. BOSCHER | 2010L'ecstasy, produit emblématique des « nouvelles drogues » dans les années 1990, a fait son chemin pour se banaliser progressivement au point, dans certains milieux, d'être considérée comme une substance démodée. Initialement consommée dans le ca[...]Livre
Quelles sont les caractéristiques sociales, économiques et culturelles des consommateurs d'ecstasy et autres "nouvelles drogues de synthèse" ? Pourquoi, où, quand, de quelle manière en font-ils usage ? Contrôlent-ils leur consommation ? Prennent[...]Périodique
J. M. DELILE | 1998FRANÇAIS : Après une présentation de l'ecstasy et des risques spécifiques liés à son usage (toxicité de la MDMA, contextes d'usage), l'auteur expose différentes actions de réduction des risques et des dommages qui peuvent être menées en matière[...]Article : Périodique
FRANÇAIS : Dans cet article, les auteurs, après avoir rappelé la place de la méthylène dioxymethamphétamine (MDMA = ecstasy) et des substances apparentées au sein de la famille chimique des phényléthylamines, comprenant également les autres dér[...]Livre
FRANÇAIS : Que se passe-t-il quand les fantasmes qu'on a dans la tête se répandent dans la vie - et vice versa ? Ces "contes de la folie ordinaire" pour une fin de siècle conjuguent plusieurs sortes d'addiction : l'amour, la vengeance, la drogu[...]Article : Périodique
This study examines how experimentation with designer drugs is mediated by the Internet. We selected a popular drug forum that presents reports on self-experimentation with little or even completely unexplored designer drugs to examine: (1) how [...]Article : Périodique
M. J. SOMMER ; S. HALTER ; V. ANGERER ; V. AUWARTER ; F. EYER ; G. LIEBETRAU ; M. EBBECKE ; M. HERMANNS-CLAUSEN |Context: New psychoactive substances (NPS) have become an ongoing threat to public health. To prevent the emergence and spread of NPS, a new German law, the 'NpSG' took effect in November 2016. This study presents an overview of analytically con[...]Article : Périodique
Aim: To evaluate the effectiveness of an online school-based prevention program for ecstasy (MDMA) and new psychoactive substances (NPS). Design: Cluster randomized controlled trial with two groups (intervention and control). Setting: Eleven s[...]Périodique
A. Y. FIRTH | 2006FRANÇAIS : La production et le trafic des drogues illicites posent un défi aux organismes chargés de lapplication de la loi. Au Canada, la production de drogues synthétiques, telle lecstasy (méthylènedioxyméthamphétamine, MDMA) et la méthamphét[...]Rapport
FRANÇAIS : Les nouvelles drogues officiellement signalées à l'OEDT et à Europol en 2009 via le système d'alerte précoce de l'UE sur les nouvelles substances psychoactives (Early-warning system/EWS) ont atteint un chiffre record. C'est ce qui se[...]Rapport
FRANÇAIS : De nouvelles substances psychoactives deviennent largement disponibles à un « rythme sans précédent ». En 2010, un nombre record de nouvelles drogues ont été officiellement signalées à l'OEDT et à Europol par le biais du système d'al[...]Rapport
FRANÇAIS : De nouvelles drogues ont été détectées dans l'Union européenne l'année dernière, à raison d'une par semaine environ, selon le rapport annuel conjoint de l'OEDT et d'Europol (2011) sur les nouvelles substances psychoactives publié auj[...]Rapport
FRANÇAIS : Le rapport annuel 2013 OEDT-Europol, qui fait le point sur les nouvelles drogues, indique que le nombre, le type et la disponibilité des nouvelles drogues en Europe ont continué à croître en 2012. Elles étaient au nombre de 49 en 201[...]Rapport
This report presents the key activities performed by the EMCDDA and Europol in 2013, with details on all the relevant activities in support of the implementation of Council Decision 2005/387/JHA on the information exchange, risk assessment and c[...]Rapport
This report presents the key activities performed by the EMCDDA and Europol in 2014, with details on all the relevant activities in support of the implementation of Council Decision 2005/387/JHA on the information exchange, risk assessment and c[...]Rapport
This report presents the key activities performed by the EMCDDA and Europol in 2017 and the results of the implementation of Council Decision 2005/387/JHA on the information exchange, risk assessment and control of new psychoactive substances, i[...]Rapport
In March 2017, the EMCDDA and Europol examined the available information on the new psychoactive substance 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)indazole-3-carboxamide, commonly known as CUMYL-4CN-BINACA, through a joint assessment. The two or[...]Rapport
In April 2014, the EMCDDA and Europol examined the available information on a new psychoactive substance 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine, commonly known as MT-45. The two organisations concluded that sufficient information had been [...]Rapport
In May 2015, the EMCDDA and Europol examined the available information on a new psychoactive substance 1-phenyl-2-(1-pyrrolidinyl)-1-pentanone, commonly known as alpha-pyrrolidinovalerophenone (alpha-PVP), through a joint assessment. The two org[...]Rapport
In September 2017, the EMCDDA and Europol examined the available information on the new psychoactive substance 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl), through a joint assessment. The two organisat[...]Rapport
The EMCDDA-Europol Joint Report on new psychoactive substance 4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine, commonly known by the abbreviation '25I-NBOMe', submitted in December 2013 to the Council of the EU, the European Commission an[...]Rapport
In February 2014, the EMCDDA and Europol examined the available information on a new psychoactive substance, 4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (commonly known by the abbreviation 4,4′-DMAR). The two organisations concluded th[...]Rapport
At the end of 2011 and in 2012, the EMCDDA and Europol examined the available information on a new psychoactive substance, 4-methylamphetamine. The two organisations concluded that sufficient information had been accumulated to merit the product[...]Rapport
At the end of September 2012, the EMCDDA and Europol examined the available information on a new psychoactive substance 5-(2-aminopropyl)indole (commonly known by the abbreviation '5-IT'), through a joint assessment. The two organisations conclu[...]Rapport
The EMCDDA-Europol Joint Report on new psychoactive substance AH-7921 (3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide), submitted in December 2013 to the Council of the EU, the European Commission and the EMA. After assessing the [...]Rapport
The EMCDDA-Europol Joint Report on new psychoactive substance MDPV (3,4-methylenedioxypyrovalerone), submitted in December 2013 to the Council of the EU, the European Commission and the EMA. After assessing the available evidence, the EMCDDA and[...]Rapport
The EMCDDA-Europol Joint Report on new psychoactive substance methoxetamine (2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone), submitted in December 2013 to the Council of the EU, the European Commission and the EMA. After assessing the availabl[...]Rapport
In May 2017, the EMCDDA and Europol examined the available information on the new psychoactive substance methyl 1-(2-phenylethyl)-4-[phenyl(propanoyl)amino]piperidine-4-carboxylate (carfentanil), through a joint assessment. The two organisations[...]Rapport
In March 2017, the EMCDDA and Europol examined the available information on the new psychoactive substance methyl 2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate, commonly known as 5F-MDMB-PINACA, through a joint asses[...]Rapport
In February 2016, the EMCDDA and Europol examined the available information on a new psychoactive substance methyl 2-[[1-(cyclohexylmethyl)indole-3-carbonyl]amino]-3,3-dimethylbutanoate, commonly known as MDMB-CHMICA, through a joint assessment.[...]Rapport
In March 2017, the EMCDDA and Europol examined the available information on the new psychoactive substance N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1- (cyclohexylmethyl)-1H-indazole-3-carboxamide, commonly known as ADB-CHMINACA, through a joint [...]Rapport
In March 2017, the EMCDDA and Europol examined the available information on the new psychoactive substance N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)- 1H-indazole-3-carboxamide, commonly known as AB-CHMINACA, through a joint asses[...]Rapport
In September 2016, the EMCDDA and Europol examined the available information on a new psychoactive substance N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide, commonly known as acryloylfentanyl, through a joint assessment. The two organisations [...]Rapport
In March 2017, the EMCDDA and Europol examined the available information on the new psychoactive substance N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl) isobutyramide, commonly known as 4-fluoroisobutyrylfentanyl (4F-iBF), through a joint ass[...]Rapport
In September 2015, the EMCDDA and Europol examined the available information on a new psychoactive substance N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (acetylfentanyl), through a joint assessment. The two organisations concluded that[...]Rapport
In September 2017, the EMCDDA and Europol examined the available information on the new psychoactive substance N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl), through a joint assessment. The two organis[...]Rapport
In March 2017, the EMCDDA and Europol examined the available information on the new psychoactive substance N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]tetrahydrofuran-2-carboxamide, commonly known as tetrahydrofuranylfentanyl (THF-F), through a [...]Article : Périodique
B. PULVER ; S. FISCHMANN ; A. GALLEGOS ; R. CHRISTIE |Synthetic cannabinoids (SCs), often sold as "legal" replacements for cannabis, are the largest group of new psychoactive substances monitored by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Currently, close to 240 struct[...]Rapport
Isotonitazene is a synthetic opioid analgesic monitored by the EMCDDA as a new psychoactive substance through the European Union Early Warning System since 2019. Based on potential public health risks, an initial report has been prepared and sub[...]Rapport
These guidelines provide the rationale, steps, procedures, roles, and responsibilities for the operation of the EU Early Warning System. They reflect the requirements of Regulation (EC) No 1920/2006 (as amended) and Council Framework Decision 20[...]Rapport
This report was compiled as a supporting document for the evaluation of the 2005-12 EU drugs strategy and its two action plans: 2005-08 and 2009-12. It reviews the main trends and changes in the European drug situation and in the responses devel[...]Article : Périodique
Le marché des drogues est en perpétuelle évolution. Le cannabis est la première substance illicite consommée dans le monde, la cocaïne a atteint la deuxième place ces dernières années. Les nouvelles drogues synthétiques, sous la dénomination de [...]Article : Périodique
A. McAULEY ; A. YEUNG ; A. TAYLOR ; S. J. HUTCHINSON ; D. J. GOLDBERG ; A. MUNRO |Background: Novel Psychoactive Substance (NPS) use has increased in recent years and generated significant concern within public health. People who inject drugs (PWID) are at increased risk of blood borne viruses, in particular Hepatitis C virus[...]Article : Périodique
Illicit drug use can result in a wide range of medical complications. As the availability, synthesis, and popularity of illicit drugs evolve over time, new syndromes associated with their use may mimic infections. Some of these symptoms are anti[...]Article : Périodique
Many new emerging drugs of abuse are marketed as legal highs despite being labeled "not for human consumption" to avoid regulation. The availability of these substances over the Internet and in "head shops" has lead to a multitude of emergency d[...]Périodique
HAROZ R. ; M. I. GREENBERG | 2005ENGLISH : Several new and emerging substances are being diverted for abuse. Most of these emerging abused substances do not cause traditional drug screens to turn positive. The health effects of these substances have not yet been fully elucida[...]Article : Périodique
We are pleased to present this special focus issue of the Journal of Medical Toxicology on emerging drugs of abuse. Since early humans first experienced euphoria with psychotropic plants more than 6,000 years ago, creative individuals have explo[...]Rapport
OEDT = EMCDDA ; D. MANSFIELD ; A. CUNNINGHAM ; L. LANIEL ; P. GRIFFITHS ; R. SEDEFOV | Lisbon : OEDT / EMCDDA | Ad hoc publication | 2020This paper provides an analysis of the available data that suggest that a methamphetamine industry is rapidly being established in Afghanistan. The analysis provided is based on information from key informants, documentary sources and the analys[...]Livre
D. N. KHEY ; J. M. STOGNER ; B. L. MILLER | Springer | Springer Briefs in Criminology, ISSN 2192-8533 | 2014Concise and timely study of emerging drug abuse trends. Examines the effect of media and the internet on semi-legal drug trends and enforcement. Includes public health and policy recommendations. This Brief explores emerging trends in drug [...]Article : Périodique
L. CHINET ; M. BERNARD ; P. STEPHAN ; A. RUBIN |Les résultats de cette enquête sont le fruit d'une collaboration entre Prevtech et le SUPEA, avec le soutien de trans'AT (JU). Ils attestent de la forte polyconsommation des amateurs les plus assidus des soirées techno, tout en mettant en éviden[...]Rapport
Au sein du pôle TREND (Tendances récentes et nouvelles drogues) de l'OFDT, les enquêtes observation du dispositif SINTES permettent d'apporter un éclairage sur la composition des substances illicites telles qu'elles sont consommées par les usage[...]Rapport
The Netherlands and Belgium are known major producers of synthetic psychoactive drugs such as MDMA, amphetamine and, more recently, methamphetamine. The present study shows that as a result of the illicit production of these synthetic drugs, lar[...]Congrès
G. HUNT ; M. MOLONEY ; ELISAD, Organisateur de réunion ; Epidemiology meets cultural studies: studying and understanding youth cultures, clubs and drugs (9-11 October 2008; Torino, Italy) ; K. EVANS | 2008ENGLISH : The public perceptions of clubs and drugs reveals the existence of two opposing discourses. One, an official discourse, characterizes dance events and taking drugs as spaces of "excess risk", which need to be controlled and regulated[...]Rapport
F. POUPON ; GREAT ; A. MOREL ; ANIT ; R. WIELAND ; ERIT | ERIT, Fédération Européenne des Associations d'Intervenants en Toxicomanie | 2001Au cours de l'année 2000, les membres du Conseil d'Administration de l'ERIT se sont interrogés sur la problématique des psychostimulants. Une action, dont cette étude est le premier pas, a alors été envisagée à l'échelon européen dans le but de [...]Rapport
FRANÇAIS : Le Rapport ESPAD 2015 présente les expériences et les perceptions des élèves concernant diverses substances, comme le tabac, l'alcool, les drogues illicites, les produit à inhaler, les médicaments et les nouvelles substances psychoa[...]Rapport
FRANÇAIS : L'usage de tabac et d'alcool chez les élèves de 15 à 16 ans donne des signes de déclin, mais la consommation potentiellement problématique de cannabis et les difficultés posées par les nouvelles conduites addictives soulèvent des in[...]Article : Périodique
Introduction: US drug overdose deaths are at historic levels. For every fatal drug overdose, there are many more non-fatal; however, minimal nationally representative data exist on trends in the ratio of fatal to non-fatal drug overdoses and how[...]Rapport
C. BEN LAKHDAR ; N. LALAM ; D. WEINBERGER ; S. SPILKA ; E. JANSSEN | Paris : INHESJ (Institut National des Hautes Etudes de la Sécurité et de la Justice) | 2015Ce document a pour objectif de présenter de façon synthétique les estimations de l'envergure, en volume et en valeur, du marché des drogues illicites en France, plus précisément celles du cannabis, de la cocaïne, de l'héroïne et une estimation i[...]Article : Périodique
F. R. LAMY ; R. DANIULAITYTE ; M. J. BARRATT ; U. LOKALA ; A. SHETH ; R. G. CARLSON |Background: Novel synthetic opioids are fueling the overdose deaths epidemic in North America.Recently, non-fentanyl novel synthetic opioids have emerged in forensic toxicological results. Cryptomarkets have become important platforms of distrib[...]Article : Périodique
This paper observes and compares discursive framings of new psychoactive substances (NPS) in parts of the mainstream media in Romania and the United Kingdom. It assembles a corpus of about 800 news items and looks into samples of reporting from [...]NouveautéArticle : Périodique
Purpose: Ethylphenidate is a novel psychoactive substance that is an analogue of methylphenidate. This paper describes its availability, patterns of use, and acute effects. Methods: Searches of the scientific and grey literature (publicly acces[...]Article : Périodique
I. A. LARABI ; A. GHISH ; P. KINTZ ; M. MARILLIER ; N. FABRESSE ; R. PELLETIER ; A. KNAPP ; A. AMELINE ; T. WILLEMAN ; Y. BARGUIL ; F. AKNOUCHE ; O. MATHIEU ; M. CHEZE ; V. LELONG-BOULOUARD ; A. MATHEUX ; E. C. LE CARPENTIER ; B. BRUNET ; N. GAMBIER ; Y. EDEL ; N. CARTISER ; V. DUMESTRE-TOULET ; S. COHEN ; B. LELIÈVRE ; J. M. GAULIER ; J. C. ALVAREZ ; A. L. PELISSIER |FRANÇAIS : Introduction: Le chemsex, phénomène récent et complexe, est de plus en plus reconnu comme un problème de santé publique. Cependant, les données françaises sur sa prévalence et ses caractéristiques spécifiques en France sont encore li[...]Rapport
This resource offers a strategic and top-level summary for policymakers and decision-makers, to support the development and implementation of policies and actions in Europe, based on a robust understanding of the current drug landscape and emerg[...]Rapport
What effect is COVID-19 having on the drug market in the EU? This joint publication from the EMCDDA and Europol analyses the impact of the pandemic on the market for the main drug types (cannabis, heroin, cocaine, amphetamines, NPS), including d[...]Rapport
Rapport
The EU Drug Markets Report 2019 is the third comprehensive overview of illicit drug markets in the European Union by the EMCDDA and Europol. The analysis presented in this report spans numerous topics such as the links between drugs and other cr[...]Rapport
FRANÇAIS : Le présent rapport analyse le phénomène du marché des drogues illicites dans le contexte plus large des nouvelles tendances en matière de consommation de drogue, des facteurs culturels et sociaux et des liens avec la criminalité. Les[...]Rapport
The EU drug markets report is the first comprehensive overview of illicit drug markets in the European Union. It covers issues such as production, consumer markets, trafficking, organised crime and policy responses, along with a review of the ma[...]Rapport
The EU SOCTA 2021 is the outcome of a detailed analysis of the threat of serious and organised crime facing the EU, providing information for practitioners, decision-makers and the wider public. As a threat assessment, the SOCTA is a forward-loo[...]Article : Périodique
FRANÇAIS : Le marché des drogues subit actuellement d'importantes mutations en raison de l'apparition d'un nombre croissant de nouvelles drogues de synthèse. Ces substances sont volontairement mises au point ou détournées de leur usage en reche[...]Rapport
FRANÇAIS : Avec une valeur estimée à 30 milliards d'EUR par an rien que dans l'Union européenne, le trafic de drogue reste un marché très lucratif au niveau mondial. Les conséquences globales pour la société sont dramatiques, en particulier pou[...]Document multimédia
FRANÇAIS : La diversification de l'offre et de l'usage de drogues crée de nouvelles problématiques pour la politique en matière de drogue, de soins et de santé en Europe. [...] Ce rapport fournit la dernière vue d'ensemble existante de la situa[...]Document texte divers
This table, a working document, lists approximately 500 substances controlled by the EU Member States and Norway, and aims to provide an at-a-glance guide as to where and if the substance is controlled within each country's legal system. Its Exc[...]Rapport
Presidency of the Council of Ministers, Department for anti-drug policies | Bruxelles : Commission Européenne / European Commission | 2015The advent of the Internet has brought about dramatic changes in our day-to-day experience, simplifying and improving our daily lives. Nonetheless, like certain other aspects of this phenomenon, its ability to give any type of user access to any[...]Rapport
OEDT = EMCDDA ; L. MONTANARI ; V. MRAVCIK ; K. GROHMANNOVA ; L. ROYUELA | Lisbon : OEDT / EMCDDA | Technical reports | 2017This is the final version of the questionnaire on drug use among prisoners at European level. The questionnaire is the results of several years of work in the field of drugs and prison, which has included the agreement on a methodological framew[...]Rapport
OEDT = EMCDDA ; T. NÉFAU ; E. LEFRANÇOIS ; V. DETREZ ; T. SEYLER ; B. GUARITA ; ESCAPE Network | Lisbon : OEDT / EMCDDA | Technical reports | 2021This protocol documents a new approach that has been developed to monitor substances injected by people who inject drugs through analytically confirmed data at the local level: the analysis of residual content of used syringes. Used syringes con[...]Rapport
Rapport
Article 5.1 of Council Decision 2005/387/JHA (hereinafter referred to as the 'Decision') stipulates that 'Where Europol and the EMCDDA, or the Council, acting by a majority of its members, consider that the information provided by the Member Sta[...]Article : Périodique
C. BOURGAIN ; B. FALISSARD ; A. LUQUIENS ; A. BENYAMINA ; L. KARILA ; L. BLECHA ; M. REYNAUD |Comme les études menées par Nutt et al., notre travail repose sur les évaluations d'experts en produits addictifs amenés à se prononcer de façon concomitante sur plusieurs produits addictifs. Ces évaluations basées sur des critères précisément d[...]Article : Périodique
J. R. H. ARCHER ; F. MENDES ; S. HUDSON ; K. LAYNE ; P. I. DARGAN ; D. M. WOOD |Aims: To evaluate the long-term trends of new psychoactive substance (NPS) detection in pooled urine samples collected across a city centre. Methods: Pooled urine samples from portable stand-alone urinals were collected on a monthly basis over[...]Rapport
FRANÇAIS : Ce rapport décrit les résultats de l'évaluation des mécanismes mis en place lors de l'adoption de "l'action commune relative à l'échange d'informations, à l'évaluation des risques et au contrôle des nouvelles drogues de synthèse", l[...]Article : Périodique
L'association Eve&Rave initie et réalise des projets de promotion de la culture techno et de réduction des risques liés à la consommation de drogues. Le travail de prévention porte essentiellement sur l'ivresse, la consommation de drogues et la [...]Rapport
The introduction of illicitly manufactured synthetic opioids to U.S. drug markets presents new challenges for contemporary drug policy: The potency of many synthetic opioids increases risk to users and poses challenges for first responders, the [...]Rapport
Ce rapport, remis en 1996, fait état du plan "Victor" à Rotterdam et de la prise en compte par les Pays-bas des remarques de la France concernant la politique néerlandaise en matière de stupéfiants. La législation est plus répressive et la polit[...]Article : Périodique
Synthetic analogs of the cathinone molecule have seen increasing recreational use as substitutes for cocaine, 3,4-methylenedioxymethamphetamine (ecstasy) and methamphetamine. Repeated use of these drugs is associated with a paranoid hallucinator[...]Congrès
Expert Seminar: Where next for Europe on drug policy reform? (20th to 21st June 2013; Lisbon, Portugal) ; IDPC ; TNI ; SICAD | London : International Drug Policy Consortium (IDPC) | 2013FRANÇAIS : Le séminaire a porté sur les aspects liés à la santé publique et le maintien de l'ordre au sein de la Stratégie sur la Drogue de l'UE, la question des nouvelles substances psychoactives, et le rôle de l'Europe dans la préparation de [...]Article : Périodique
C. L. ARFKEN ; D. OWENS ; C. MADEJA ; C. DEANGELIS |The use of synthetic cannabinoids and cathinones in southeastern Michigan was explored using Roger's Diffusion of Innovation theory. A mixed methods approach after specific synthetic cannabinoids and cathinone compounds were scheduled was used t[...]Article : Périodique
The heterogeneous group of recreational drug users is usually inconspicuous in society. These individuals do not regard themselves as drug users in a conventional way and therefore hardly can be reached through traditional methods (e.g. heavy dr[...]Rapport
OEDT = EMCDDA ; J. MOUNTENEY ; T. GROSHKOVA ; D. THANKI ; A. CUNNINGHAM ; M. RYCHERT | Lisbon : OEDT / EMCDDA | EMCDDA Papers, ISSN 2315-1463 | 2014Concerns about the availability and use of methamphetamine in Europe have been growing for some time. Historically, the use of methamphetamine has been confined largely to the Czech Republic and Slovakia; however, recent signs of the spread of m[...]Périodique
C. GROV ; D. S. BIMBI ; NANIN J. E. ; J. T. PARSONS | 2006Reported rates of recreational drug use among gay and bisexual men are currently rising. Although there has been much empirical research documenting current trends in drug use among gay and bisexual men, little research has empirically contraste[...]Article : Périodique
A growing number of New Psychoactive Substances (NPS) appear yearly on the European market (81 for the first time in 2013, adding to a total of over 350 NPS). Using semi-structured interviews with 25 Dutch experienced recreational drug users, th[...]Article : Périodique
S. FÉREC ; M. BRETAUDEAU DEGUIGNE ; B. LELIÈVRE ; D. BOELS ; C. BRUNEAU ; I. LEBORGNE ; P. HARRY ; B. DIQUET ; A. TURCANT |FRANÇAIS : 3,4-méthylènedioxypyrovalérone (MDPV) et méthoxétamine (MXE) font partie des nouvelles substances dites «récréatives» facilement obtenues sur Internet. Neuf cas d'exposition à ces substances sont rapportés pour 8 patients, l'un d'ent[...]Article : Périodique
Alpha-methyltryptamine (MT/AMT) is a currently legal new psychoactive substance. It is a long acting, synthetic psychedelic.Article : Périodique
Etizolam is a benzodiazepine analogue. It has gathered some popularity on the new psychoactive substance (NPS) market in the UK and Europe. It has a broadly similar pharmacological profile to benzodiazepine drugs such as diazepam. A 1mg tablet i[...]Article : Périodique